A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection
PHASE1
This trial is a randomized, double-blind, three-arm, parallel-group, pharma...
Status
Completed
Location
Parexel International GmbH, Early Phase Clinical Unit Berlin